- Portola Pharmaceuticals (PTLA -7.1%) falls sharply after announcing a $100M public offering.
- The deal will reportedly include shares from selling stockholders.
- The company intends to use a portion of the proceeds to "support the pursuit of an accelerated approval process for Andexanet alfa." (PR)
Portola Pharmaceuticals sinks on news of public offering
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PTLA | - | - |
Portola Pharmaceuticals, Inc. |